SOLARIS Trademark

Trademark Overview


On Wednesday, September 18, 2024, a trademark application was filed for SOLARIS with the United States Patent and Trademark Office. The USPTO has given the SOLARIS trademark a serial number of 98757120. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Friday, September 26, 2025. This trademark is owned by Solaris Endovascular, Inc.. The SOLARIS trademark is filed in the Medical Instrument Products category with the following description:

Stents; Stent delivery systems
solaris

General Information


Serial Number98757120
Word MarkSOLARIS
Filing DateWednesday, September 18, 2024
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateFriday, September 26, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesStents; Stent delivery systems

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, September 18, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSolaris Endovascular, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew Orleans, LA 70170

Trademark Events


Event DateEvent Description
Wednesday, September 18, 2024NEW APPLICATION ENTERED
Wednesday, March 26, 2025ASSIGNED TO EXAMINER
Wednesday, March 26, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 26, 2025NON-FINAL ACTION WRITTEN
Tuesday, March 25, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, March 26, 2025NON-FINAL ACTION E-MAILED
Thursday, June 26, 2025APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Friday, September 26, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 26, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 26, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 26, 2025APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

Related Keywords


solaris systems delivery stent stents